|
“Our goal is to harness the power
of Nutritional Genomics. We aim to understand genetic variations
in the metabolism of specific nutrients, beginning with
L-Arginine, and to develop methodologies specifically addressing
and ameliorating genetic variants.”
|
|
|
| |
“Encode ® is being hailed as one of the most
important and significant research projects in the field
of human health. Imagine being able to treat Sickle Cell
Disease and Thalassemia with a cherry-drink that has no
side effects and no chemicals. So many children suffer with
these diseases globally – it is for them that we strive
to find solutions hidden within the DNA.”
Dr.
Ann de Wees Allen
Chief of Research
Encode® Research Project |
|
|
Genetic
Breakthrough
Announced by Medical Community
Top Researchers Break the Code to Genetic
Diseases Sickle Cell & Thalassemia
|
|
 |
Scientists
have discovered the Key Code to a new treatment for Sickle
Cell Disease and Thalassemia, the number one genetic disease
in the world.
Fellow researchers named the group The Dream Team due to their
groundbreaking research and discoveries in the field of NutraGenomics.
|
|
| Touted
globally as one of the most important discoveries of this century,
researchers say that “This discovery may well be worthy of
the Nobel Prize in Medicine.”
Chief
Research Scientist
Encode® Research Project |
 |
Dr.
Ann de Wees Allen |
|
| |
| •
|
Chief
of Biomedical Research at the Glycemic Research Institute
in Washington, D.C., |
| •
|
Named the
World’s Leading L-Arginine Researcher |
| •
|
Received
the first Glycemic Patent ever awarded |
| •
|
Discovered
that L-Arginine is a Blind Amino Acid ® |
| •
|
Patents
Held: L-Arginine Biochemistry and Safe L-Arginine in Humans |
| • |
27-years
of research in the field of L-Arginine biochemistry |
| • |
Conducts
Human In Vivo Clinical Trials for the U.S. Government, as
well as the largest food companies in the world, including
Proctor & Gamble and Hershey Foods, |
| • |
Who’s
Who of American Inventors |
|
Encode®
Patents Pending in Genetic Polymorphisms
|
|
